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Introduction 
In patients with atrial fibrillation (AF), most thrombus formation occurs in the left 
atrial appendage (LAA) because the saccate and complex morphology of the LAA 
induces stasis of blood flow.
1
 The CHADS2 and CHA2DS2-VaSc scores are indices of 
thromboembolic risk for patients with AF.
2,3
 Of the echocardiographic indices, left 
ventricular systolic dysfunction, dense spontaneous echo contrast (SEC), low LAA peak 
flow velocities, and complex aortic plaque were reported to be related to 
thromboembolic risk.
4-5
 However, whether LAA morphology itself is a risk factor for 
LAA thrombus formation has not been well studied. Recently, Di Biase et al. assessed 
the LAA with computed tomography or magnetic resonance imaging and reported the 
types of morphology related to thromboembolic risk.
6
 That report strongly suggests that 
LAA morphology is a risk factor for LAA thrombus formation; however, the relation 
between presence of LAA thrombus and types of LAA morphology has not been 
clarified. Although computed tomography and magnetic resonance imaging have been 
used to assess LAA morphology,
 6-8
 initial studies with three-dimensional (3D) 
transesophageal echocardiography (TEE) have also shown the potential to assess LAA 
morphology.
9,10
 Recently, our coworkers reported that 3D-TEE could evaluate the LAA 
volume, orifice area, depth and number of LAA lobes from reconstructed 3D LAA 
2 
 
images.
11
 Therefore, the aim of our study was to clarify the relation between LAA 
morphology evaluated with 3D-TEE and LAA thrombus in patients with AF in 
comparison with conventional indices. 
 
Methods 
Study Population and Study Protocol 
Between April 2008 and February 2012, 633 consecutive patients who were candidates 
for catheter ablation for symptomatic drug-resistant AF at the University of Tsukuba 
Hospital were prospectively enrolled in this study (Table 1). Among them, patients with 
inadequate TEE imaging quality and severe mitral or aortic valvular diseases and those 
undergoing hemodialysis or not receiving anticoagulation therapy with warfarin were 
excluded. 
On the day before catheter ablation, transthoracic echocardiography and TEE 
examinations were performed to identify the presence of LAA thrombus in all patients. 
Anticoagulation management of warfarin was in accordance with the guideline of The 
Japanese Circulation Society.
12
 In the guideline, the target INR is 2.0 to 3.0 for patients 
under 70 years and 1.6 to 2.6 for patients 70 years of age or older because an INR of 
more than 2.6 increases the risk for serious bleeding complications in the Japanese 
elderly population. All patients received therapeutic anticoagulation therapy at least 
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over the 3 weeks before TEE. 
Sequential TEE examinations were also performed in patients who had maintained 
sinus rhythm for at least 1 year after catheter ablation to clarify the contribution of AF 
to left atrium and LAA morphology and function. Ethical approval of the present study 
was obtained from the local review committee, and all patients provided their written 
informed consent. 
 
Echocardiographic Studies 
Standard two-dimensional transthoracic echocardiographic examinations were 
performed with an iE33 ultrasound system and S5-2 probe (Philips Medical Systems, 
Andover, MA). Left ventricular end-diastolic volume, end-systolic volume, and ejection 
fraction (LVEF) were measured using the modified Simpson’s method from the apical 
view.
13
 The LA volume was measured using the modified Simpson’s method from the 
apical view.
14
 
TEE was performed with an iE33 ultrasound system and S7-2 probe (Philips 
Medical Systems). SEC was visually classified into four grades by careful attention to 
the gain settings adjusted to distinguish background white noise.
15
 The severity of SEC 
was scored as follows: 0: absence of echogenicity, 1+: mild (minimal echogenicity 
detectable in only a part of the LA cavity with high gain settings), 2+: moderate (denser 
4 
 
swirling during the entire cardiac cycle), and 3+: severe (intense echodensity and very 
slow swirling patterns in the LAA usually with similar density in the main cavity) as 
defined in a previous report. Reproducibility of the SEC grade was evaluated between 2 
observers in 50 patients selected at random, and the concordance rate was 92% (46/50). 
Based on the recommendations from the American Society of Echocardiography,
16
 
blood stasis was quantified by LAA flow velocities, which were measured at 
approximately 1 cm below the outlet of the LAA cavity using pulsed Doppler. LAA 
emptying flow velocity was measured in the basal short-axis view from the transverse 
scan (45° views). The LAA emptying and filling flow velocities were measured as the 
average of 3 consecutive cardiac cycles in patients with normal sinus rhythm (NSR) and 
5 consecutive cardiac cycles in patients with AF. Full-volume mode examinations were 
performed from 45° views during apnea at end-expiration. To obtain these datasets, 6 
sectors were scanned with gating to the electrocardiographic R wave and were 
automatically integrated into a wide-angle (76×69 degrees) pyramidal data image 
covering the entire LAA. The frame rate of each image was set at approximately 20 to 
30 frames/s. In patients with AF during the examination, zoom mode, which magnified 
the pyramidal scan by 1 cardiac beat, was used. The frame rate of each image was set at 
approximately 10 frames/s. 
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Quantification of LAA Morphology 
Quantification of LAA morphology was performed with QLAB GI-3DQ software 
(Philips Medical Systems). First, multi-reconstruction planes of the LAA were obtained 
from 3D datasets (pyramidal images) including the LAA at end-systole. The method of 
determining LAA orifice size is shown in Figure 1A and B.
17,18
 We measured the LAA 
orifice long and short diameters, orifice area (Figure 1C), and depth of the orifice to a 
lobe tip (Figure 1B). 
The inner border of the LAA was manually traced within the distal area of the 
orifice, and the transverse images of the longest axis of the LAA trace area were 
automatically sliced at 10 levels from the orifice to the most distal site. On each sliced 
transverse image, the inner border was manually traced and reconstructed into a 3D 
image (Figure 2). On a reconstructed image, we measured LAA volume and the number 
of LAA lobes, which was assessed based on the definitions by Veinot et al.
19
 as follows: 
“1) LAA lobe was a visible out-pouching from the main tubular body of the LAA, 
usually demarcated
 
by an external crease; 2) it was internally capable of admitting
 
a 
2-mm probe (i.e., it was not simply a tag of external adipose tissue);
 
3) it was 
occasionally but not necessarily associated with
 
a change in direction of the main 
tubular body of the LAA; 4)
 
it could lie in a different anatomic plane than the main 
tubular
 
body; and 5) by definition, the LAA must have at least 1
 
lobe.” Intraobserver 
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and interobserver variability of these parameters was less than 10% in our previous 
study.
11
  
 
Clinical Risk Stratification 
We calculated CHADS2 score for clinical risk stratification of stroke in patients with 
AF.
2
 Some clinical studies have reported a relation between inflammation and AF,
20
 and 
C-reactive protein (CRP) is a representative marker of vascular inflammation. B-type 
natriuretic peptide (BNP) is a marker that increases in patients with structural heart 
disease, heart failure, and lone AF. It has been reported that the atrium, and not the 
ventricle, is the main source of BNP in patients with AF,
21
 and BNP is higher in patients 
with a history of thromboembolism than in patients without this complication.
22
 
Therefore, blood samples to measure plasma high-sensitivity CRP, BNP concentration, 
and prothrombin time/international normalized ratio (INR) were obtained at the time of 
TEE examinations. 
 
Catheter Ablation 
Three long sheaths were advanced into the LA. Following pulmonary vein angiography, 
2 decapolar ring catheters (Lasso, Biosense Webster, Diamond Bar, CA) were placed in 
the superior and inferior pulmonary veins on one side at a time. An open-irrigation, 
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3.5-mm-tip deflectable catheter (ThermoCool; Biosense Webster) was used for mapping 
and ablation. The LA and pulmonary veins were constructed with a 3-dimensional 
electro-anatomic mapping system (CARTO; Biosense Webster). The ipsilateral 
pulmonary vein antrum was circumferentially ablated under fluoroscopic, electrogram, 
and CARTO guidance. Radiofrequency energy was delivered at a power of 20-35 W. 
The endpoint of ablation was the elimination of all pulmonary vein potentials. 
 
Statistical Analysis 
Results are expressed as number (%) or as mean ± SD. Comparisons between two 
groups were performed with the Student t-test for continuous variables and the Fisher’s 
exact test for categorical variables. One-way analysis of variance (ANOVA) with the 
post-hoc Tukey-Kramer test was used to compare variables between three or more 
groups. Multiple logistic analysis was performed to identify independent risk factors for 
LAA thrombus. A P value of <0.05 was considered to indicate statistical significance. 
These analyses were performed with SPSS version 17.0 for Windows (SPSS Inc., 
Chicago, IL). 
 
Results 
TEE examinations were successfully performed in all patients. We excluded 69 (10.9%) 
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patients because of inadequate imaging quality for LAA analysis (n=42), not receiving 
anticoagulation therapy with warfarin (n=12), severe mitral regurgitation (n=8), 
undergoing hemodialysis (n=5), and severe mitral stenosis (n=2). Finally, this study 
comprised 564 patients. Among them, LAA thrombus was observed in 36 (6.4%) 
patients. Comparisons between patients with and without LAA thrombus are 
summarized in Table 2. Patients with LAA thrombus had a significantly higher 
prevalence of non-paroxysmal AF (P<0.001). Patients with LAA thrombus were 
significantly older (P=0.003) and their LVEF was lower (P<0.001) and CHADS2 score 
higher (P<0.001) than those in patients without LAA thrombus. There was no 
significant difference in prothrombin time/INR between the 2 groups. In patients with 
LAA thrombus, plasma high-sensitivity CRP (P<0.001) and BNP (P<0.001) 
concentrations were significantly higher than those in patients without LAA thrombus. 
In patients with LAA thrombus, LAA volume (P<0.001) and LA volume (P<0.001) 
were significantly larger with larger LAA orifice area (P<0.001) and deeper LAA depth 
(P<0.001) in comparison with those in patients without LAA thrombus. In addition, the 
number of LAA lobes was significantly higher (P<0.001) than that of the patients 
without LAA thrombus. Degree of SEC was significantly higher (P<0.001) with lower 
LAA emptying velocities (P<0.001) compared with those in patients without LAA 
thrombus. 
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Risk Factors for LAA Thrombus 
Various factors had a significant relation with the presence of LAA thrombus as shown 
in Table 3. In a multivariate logistic analysis, number of LAA lobes (OR 2.469, 95% CI 
1.495-4.078, P<0.001) was identified as an independent risk factor for presence of LAA 
thrombus, as were CHADS2 score (OR 1.752, 95% CI 1.237-2.483, P=0.002 ), LVEF 
(OR 0.962, 95% CI 0.934-0.992, P=0.01), LA volume (OR 1.018 , 95% CI 1.003-1.032, 
P=0.02), and degree of SEC (OR 1.783, 95% CI 1.102-2.740, P=0.02). Prevalence of 
the number of LAA lobes is shown in Figure 3. The majority of patients with LAA 
thrombus (32/34, 94.4%) had 3 or more LAA lobes. In contrast, LAA thrombus was 
observed in only 2 (0.7%) of 296 patients with 1 or 2 lobes. In a multiple logistic 
regression analysis model, as compared with an LAA with 1 or 2 lobes, an LAA with 3 
lobes was 8.6 times (OR 8.6, 95% CI 1.9-39.8, P=0.006), 4 or 5 lobes was 10 times (OR 
10.0, 95% CI 2.2-42.1, P=0.004), and 3 or more lobes was 9.2 times (OR 9.2, 95% CI 
2.0-41.1, P=0.004) more likely to have thrombus. 
The relation of number of LAA lobes with degree of SEC and LAA empting 
velocity is shown in Figure 4. In patients with 3 or more LAA lobes, a higher degree of 
SEC (Figure 4A) and lower LAA empting velocity (Figure 4B) were observed as 
compared with those in patients with 1 or 2 LAA lobes. 
10 
 
 
Risk Factors for LAA Thrombus in Patients with Low CHADS2 Score 
Patients with LAA thrombus included 13 (13/198, 6.6%) with a CHADS2 score of 1 and 
1 (1/185, 0.5%) patient with a CHADS2 score of 0. In a multiple logistic regression 
analysis model for LA thrombus in only limited patients with CHADS2 score 0/1, 
number of LAA lobes (OR 2.8, 95% CI 1.3-6.1, P=0.008) was identified as a significant 
predictor as were SEC (OR 3.1, 95% CI 1.5-6.6, P=0.003) and LVEF (OR 0.9, 95% CI 
0.89-0.98, P=0.022). Unlike the analysis in the overall population, LA volume was not a 
significant predictor. 
 
Functional and Morphological Changes After Catheter Ablation 
Repeat TEE examinations were performed in 46 patients who maintained sinus rhythm 
over 1 year after catheter ablation. Average term from catheter ablation to next TEE 
examination was 19.2 ± 5.3 months. A representative case is shown in Figure 5. The 
LAA volume decreased after catheter ablation from 17.8 ml to 10.3 ml, while number of 
lobes and fundamental morphology was maintained. Comparison of clinical 
characteristics and echocardiographic measurements between baseline and after catheter 
ablation are summarized in Table 4. After catheter ablation, plasma high-sensitivity 
CRP (P=0.04) and BNP (P<0.001) concentrations were decreased, and LVEF 
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(P=0.002) was increased. In addition, significant reverse remodeling of both the left 
atrium (P<0.001) and LAA (P<0.001) were observed with improvements of blood stasis 
represented as SEC (P<0.001) and LAA emptying velocity (P=0.02). However, the 
number of lobes did not change in any of the patients. 
 
Discussion 
This is the first study, to our knowledge, to examine the relation between LAA 
morphology assessed by 3D-TEE and LAA thrombus formation in patients with AF. 
We found a significant relation between LAA morphology and the prevalence of LAA 
thrombus formation; in particular, number of LAA lobes was identified as an 
independent risk factor for LAA thrombus. The LAA with multiple lobes is thought to 
have a more complex morphology. Therefore, we believe that complex LAA 
morphology should be considered as a novel risk factor for the formation of LAA 
thrombus in patients with AF, as well as CHADS2 score, LA volume, LVEF, and degree 
of SEC, which are other well-known risk factors of LAA thrombus. 
In patients who maintained sinus rhythm during the first year after catheter ablation, 
LA and LAA volumes were decreased, but number of LAA lobes did not change. This 
finding indicates that the number of LAA lobes is a congenital characteristic and is not 
influenced by LAA remodeling. Accordingly, the complexity of the LAA, which is 
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represented by the number of LAA lobes, may be a congenital and specific factor in 
each individual. Several prior studies have reported on the diversity of LAA lobes and 
their geometry.
6-10,19,23
 In a large autopsy series comprising 500 normal human hearts 
(age range 0 to 100 years), the distribution of the number of LAA lobes was 2 (54% of 
hearts), 3 (23%), 1 (20%), and 4 (3%).
19
 In our study, the distribution was 2 (42.2%), 3 
(34.9%), 1 (10.3%), 4 (11.3%), and 5 (1.2%). Mean number of LAA lobes is 2.1 in the 
autopsy study and 2.5 in our study, and there was a statistically significant difference by 
chi-square test (P<0.01). The difference might be caused by study populations, namely, 
our study consisted of patients with AF, in contrast to the normal hearts in the autopsy 
study. 
Di Biase et al. categorized LAA into four different morphologies and reported that 
the Chicken Wing LAA morphology was less likely to produce an embolic event.
6
 We 
did not analyze morphology type in the present study; however, morphology such as the 
Chicken Wing type is the simplest among the Di Biase et al. classification and may 
correspond to the LAA with 1 or 2 lobes in our study. Di Biase et al. did not discuss the 
reason why simple LAA morphology was related to a lower embolic event rate. As it is 
assumed that a simple morphology is less likely to induce blood stasis, the present study 
clearly revealed that an increase in the number of LAA lobes was related to a high 
degree of SEC and low LAA empting velocity. The findings suggest that complex LAA 
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morphology characterized by an increased number of lobes is likely to induce blood 
stasis, which is a fundamental cause of thrombus formation. 
CT and MRI are useful methods of characterizing the LAA; however, image quality 
is severely deteriorated by stitching artifact in patients with AF during the examination. 
We used zoom mode, which magnified the pyramidal scan by 1 cardiac beat in patients 
with AF during the examination, so we could avoid stitching artifact. Moreover, CT has 
a problem of radiation exposure and both methods require use of a contrast agent, so it 
is difficult to use in patients with severe renal dysfunction. In most hospitals, TEE was 
generally performed before catheter ablation for AF to assess LAA thrombus. TEE has 
the advantage of assessing LAA morphology in routine clinical practice. 
Because we managed anticoagulation based on the guideline of the Japanese 
Circulation Society, the target ranges differ slightly from those in the AHA guidelines 
or those of other western countries. The Japanese Circulation Society guideline 
recommends a basic target INR of 2.0 to 3.0. However, in patients 70 years of age or 
older, the recommended target INR is 1.6 to 2.6 because an INR of more than 2.6 
increases the risk for serious bleeding complications in the Japanese elderly population. 
In our patients without thrombus, 482 (482/528, 91.3%) achieved the target INR, and in 
patients with thrombus, 33 (33/36, 91.7%) achieved the target INR. In the 3 patients 
with thrombus who did not achieve the target INR, thrombus formation might be due to 
14 
 
poor warfarin control. However, the INR in these 3 patients was not much lower than 
the target INR (every patient exceeded an INR of 1.5) because they were all older than 
70 years of age. Therefore, most patients with thrombus were treated within the target 
INR. 
Plasma CRP concentrations in patients with LAA thrombus were increased over 
those in patients without LAA thrombus. Previous studies reported that CRP and 
interleukin-6 were elevated in patients with AF, and elevated inflammatory markers are 
related to embolic events.
24,25
 Our findings support these results, but multivariate 
analysis could not identify the independent strength of the association of these variables 
with LAA thrombus as compared with that of LAA morphology and blood stasis. 
Because a significant relation between inflammation and LA remodeling has been 
observed, the inflammation process may indirectly contribute to LAA thrombus 
formation via LA and/or LAA remodeling. 
 
Clinical Implications 
In this study, we clarified the relation between LAA morphology and thrombus 
formation. In the clinical setting, we have used the CHADS2 or CHA2DS2-VaSc score 
for thromboembolic risk stratification. However, in cases of high bleeding risk or low 
CHADS2 score (0 or 1), both bleeding risk due to anticoagulation therapy and 
15 
 
thromboembolic risk should be considered. Furthermore, in patients who have 
maintained sinus rhythm for a long time after catheter ablation, we wonder whether 
anticoagulation therapy should be continued. Knowledge of the number of LAA lobes 
would be helpful in making clinical decisions on antithrombotic therapy in such 
controversial cases. However, thrombus is a cause of stroke, and thrombus formation is 
no more than a surrogate for stroke risk. In the future, long-term follow-up studies 
identifying how the number of LAA lobes together with the CHADS2 score influences 
the risk of stroke as an end-point are needed. 
 
Study Limitations 
Forty-two patients (6.6%), most of whom were in an AF rhythm at the time of TEE 
examination, were excluded because of inadequate 3D LAA image quality. Because the 
full-volume imaging method derived from 6 cardiac beats was not available in patients 
with AF, the single-beat image acquisition method (zoom-mode imaging) was used, 
which may exacerbate image quality in assessing LAA morphology in patients with AF. 
From the statistical aspect, there is a great difference between the number of patients 
with thrombus (n=528) and without thrombus (n=36). Therefore, comparisons between 
two groups are limited statistically. Furthermore, our study was a single-center study, 
and the study population was limited to patients undergoing catheter ablation and 
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anticoagulation therapy with warfarin for AF. To confirm whether this study is 
applicable to a wider population not undergoing catheter ablation or taking warfarin, a 
multicenter study consisting of a larger number of participants with diverse diagnoses is 
necessary. 
 
Conclusions 
Complex LAA morphology that was characterized by an increased number of LAA 
lobes was associated with the presence of LAA thrombus, independently of clinical risk 
and blood stasis. Our study suggested that LAA morphology might be a congenital risk 
factor for LAA thrombus formation in patients with AF. Accordingly, analysis of LAA 
morphology may provide additional information in the diagnosis of LAA thrombus and 
in decision making and formulation of medical strategies including anticoagulation 
management. 
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Table 1  Baseline Characteristics and Echocardiographic Measurements 
Variable                                             Value (N=633) 
Men/Women 512/121 
Age (years)    62 ± 11 
Heart rate    67 ± 16 
Co-morbidities  
Paroxysmal atrial fibrillation 373 (59%) 
Non-paroxysmal atrial fibrillation 260 (41%) 
Rhythm at examination  
Normal sinus rhythm 365 (58%) 
Atrial fibrillation 268 (42%) 
Measurements on 2D transthoracic echocardiography  
Left ventricular end-diastolic volume (ml) 101 ± 36 
Left ventricular end-systolic volume (ml)     38 ± 26 
Left ventricular ejection fraction (%)     63 ± 11 
Left atrial volume (ml)      63 ± 29  
  Data are expressed as mean ± SD or as number (percentage). 
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Table 2  Baseline Characteristics According to Presence of LAA Thrombus 
    
Variable 
No thrombus 
(n = 528) 
Thrombus 
(n = 36) 
p Value 
Age (years) 61 ± 11 67 ± 8 0.003 
AF type (Non-paroxysmal AF) 186 (35%) 26 (72%) 0.0001 
Sex (male)  424 (80%) 33 (92%) ns 
PT-INR 1.92 ± 0.31 2.15 ± 0.42 ns 
hs-CRP (mg/dl) 0.18 ± 0.42 0.44 ± 0.65 0.0004 
BNP (mg/dl)  97.1 ± 139.1 291.2 ± 288.8 <0.0001 
CHADS2 score 1.1 ± 1.1 2.2 ± 1.3 <0.0001 
Left ventricular ejection fraction (%) 64 ± 10 51 ± 18 <0.0001 
Left ventricular end-diastolic volume (ml) 99 ± 32 129 ± 68 <0.0001 
Left atrial volume (ml) 61 ± 26 99 ± 45 <0.0001 
Degree of spontaneous echo contrast  0.6 ± 1.0 2.1 ± 1.1 <0.0001 
LAA emptying velocity (cm/s) 46 ± 21 28 ± 17 <0.0001 
LAA orifice area (cm2) 4.4 ± 3.1 6.3 ± 3.0 0.0006 
LAA depth (mm) 34 ± 11 42 ± 12 <0.0001 
LAA volume (ml) 7.6 ± 7.1 12.1±5.8  0.0003 
Number of LAA lobes 2.5 ± 0.8 3.4 ± 0.8 <0.0001 
Data are expressed as mean ± SD or as number (percentage). 
AF = atrial fibrillation; BNP = B-type natriuretic peptide; CHADS2 = Congestive heart failure, 
Hypertension Age > 75, Diabetes mellitus and prior Stroke or transient ischemic attack; LA = left 
atrium, LAA = left atrial appendage; PT-INR = prothrombin time/international normalized ratio. 
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Table 3  Univariate and Multivariate Analysis for Presence of LAA Thrombus 
 
Univariate Multivariate 
Variable OR (95% CI) p Value OR (95% CI) p Value 
AF type (Non-paroxysmal AF) 4.785 (2.26-10.10) <0.0001 
 
ns 
CHADS2 score 1.915 (1.486-2.467) <0.0001 1.752 (1.237-2.483) 0.0016 
Degree of spontaneous echo contrast 3.128 (2.262-4.326) <0.0001 1.783 (1.102-2.740) 0.0174 
Left ventricular ejection fraction (%) 0.935 (0.914-0.956) <0.0001 0.962 (0.934-0.992) 0.0122 
LA volume (ml) 1.031 (1.021-1.041) <0.0001 1.018 (1.003-1.032) 0.016 
LAA emptying velocity (cm/s) 0.947 (0.925-0.970) <0.0001 
 
ns 
LAA volume (ml) 1.038 (1.007-1.070) 0.0152 
 
ns 
Number of LAA lobes 3.318 (2.179-5.052) <0.0001 2.469 (1.495-4.078) 0.0004 
  CI = confidence interval; OR = odds ratio. Other abbreviations as in Table 2. 
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Table 4  Clinical Characteristics and Echocardiographic Measurements in Patients Who Maintained 
Sinus Rhythm After radiofrequency catheter ablation  
Variable Baseline After RFCA p Value 
Men/Women 36/10 -  
Age (years) 62 ± 9 -  
BNP (mg/dl) 124 ± 135 44 ± 52 0.0002 
hs-CRP (mg/dl) 0.13 ± 0.14 0.09 ± 0.10 0.04 
Left ventricular ejection fraction (%) 65 ± 10 69 ± 8 0.002 
Left ventricular end-diastolic volume (ml) 103 ± 33 104 ± 27 ns 
Left ventricular end-systolic volume (ml)  37 ± 20  33 ± 12 0.03 
E  78 ± 20  72 ± 20 ns 
E’  9.5 ± 2.6 13 ± 9 0.001 
E/E’  8.6 ± 2.9  8.3 ± 3.3 ns 
Left atrial volume (ml)  73 ± 25  63 ± 24 0.0001 
LAA emptying velocity (cm/s)  38 ± 19  44 ± 19 0.02 
LAA filling velocity (cm/s)  43 ± 22  46 ± 18 ns 
LAA orifice area (cm
2
)  4.4 ± 1.4  4.0 ± 1.2 0.003 
LAA depth (mm) 37 ± 8 36 ± 7 0.002 
LAA volume (ml)  7.4 ± 2.9  6.7 ± 2.6 0.0009 
Number of LAA lobes  2.6 ± 0.7  2.6 ± 0.7 ns 
Degree of spontaneous echo contrast  1.3 ± 1.2 0.70 ± 0.9 <0.0001 
  Data are expressed as mean ± SD or as number (percentage). 
  RFCA = radiofrequency catheter ablation, LAA = left atrial appendage. 
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Figure 1  Determination of the Left Atrial Appendage Orifice 
 
 
 
 
 
 
(A) Left atrial appendage (LAA) long-axis view at the level including the 
mitral valve annulus, left coronary artery (white arrow), and lateral ridge of 
the left superior pulmonary vein (white arrowhead). (B) LAA long-axis view 
at the level including the aortic valve annulus (white arrows). The dashed 
line with double-headed white arrows in both (A) and (B) corresponds to the 
line to determine the orifice of the LAA as shown in (C). In (B), the dotted 
line shows LAA depth. (C) LAA orifice area and long and short diameters. 
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Figure 2  Representative Reconstructed 3D Images of the Left Atrial 
Appendage 
 
 
The reconstructed 3D image is of a left atrial appendage (LAA) with single 
lobe in panel A, an LAA with 2 lobes in panel B, and an LAA with 3 lobes in 
panel C. The green line indicates the coronal section line for ultrasonic beam 
direction, and the red line indicates the section line for a sagittal section. 
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Figure 3  Prevalence of Number of Left Atrial Appendage Lobes Between 
Patients With and Without Thrombus 
 
 
The graphs show the difference in the prevalence of number of left atrial 
appendage (LAA) lobes between patients without LAA thrombus (A) and 
with LAA thrombus (B). Most patients in the group without LAA thrombus 
(A) had 2 LAA lobes, whereas most patients in the group with LAA thrombus 
had 3 or more lobes. 
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Figure 4  Degree of Blood Stasis According to Number of Left Atrial 
Appendage Lobes 
 
 
Panel A shows comparisons of the degree of spontaneous echo contrast (SEC) 
according to numbers of left atrial appendage (LAA) lobes. Panel B shows 
comparisons of LAA empting velocity. *p < 0.05 vs. 1 lobe group; †p < 0.05 vs. 
2 lobes group; ‡p < 0.05 vs. 3 lobes group 
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Figure 5  Representative Case of Left Atrial Appendage Remodeling After 
Catheter Ablation 
 
 
The upper panel (A) shows baseline left atrial appendage (LAA) images and 
the lower panel (B) shows the corresponding images after catheter ablation. 
The image in the red frame shows a short-axis view of the apex of the LAA 
lobe, that in the blue frame shows an LAA long-axis view (sagittal plane), 
and that in the green frame shows an LAA long-axis view (horizontal plane). 
The rightmost image shows a 3D LAA image. The green line in the 3D LAA 
image indicates the horizontal section line for ultrasonic beam direction, the 
red line indicates a coronal section, and the blue line indicates a sagittal 
section. The LAA was reduced in size after catheter ablation (LAA volume, 
17.8 ml to 10.3 ml; length of LAA neck, 23 mm to 14 mm), while the number 
of lobes (＊) and fundamental morphology were maintained.
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